Table 2 Comparison of laboratory results between the progression group and the non-progression group at first /follow-up visits

Fasting glucose (mmol/L)

6.15 ± 1.81

5.49 ± 1.25

<0.001

7.84 ± 1.80

5.30 ± 1.22

0.005

OGTT (mmol/L)

10.09 ± 4.17

8.65 ± 3.41

<0.001

9.68 ± 3.79

8.47 ± 3.38

0.002

Fasting insulin (mU/L)

13.50 ± 26.58

12.57 ± 27.04

0.010

14.43 ± 19.01

17.10 ± 60.81

0.002

Postprandial insulin (mU/L)

78.31 ± 117.74

62.43 ± 65.86

0.388

80.27 ± 71.31

88.35 ± 107.35

0.868

Bennett index

1.79 ± 0.65

0.41 ± 0.56

<0.001

0.95 ± 0.84

0.67 ± 0.95

<0.001

HbA1c (%)

6.73 ± 1.40

6.24 ± 0.98

0.001

6.79 ± 1.53

6.07 ± 0.78

<0.001

hsCRP (mg/L)

9.28 ± 13.56

13.34 ± 22.51

0.600

6.55 ± 12.01

2.68 ± 4.14

0.048

BUN (mmol/L)

5.44 ± 1.59

5.45 ± 1.50

0.941

6.06 ± 1.90

5.70 ± 1.48

0.623

Creatinine (umol/L)

84.47 ± 18.34

89.90 ± 36.51

0.671

93.11 ± 23.46

87.28 ± 18.87

0.585

Urine acid (umol/L)

339.83 ± 76.41

339.30 ± 85.77

0.878

358.38 ± 81.25

362.80 ± 79.00

0.966

Urine Ma/Cr

12.12 ± 49.70

3.65 ± 18.74

0.011

16.00 ± 69.94

2.09 ± 3.14

0.366

GFR (ml/min)

80.16 ± 25.46

76.62 ± 28.98

0.345

73.52 ± 25.48

71.55 ± 23.33

0.049

Serum triglyceride (mmol/L)

2.13 ± 1.72

1.86 ± 2.01

0.072

1.76 ± 1.34

1.65 ± 1.50

0.207

Serum cholesterol (mmol/L)

4.58 ± 1.22

4.18 ± 1.09

0.103

2.08 ± 0.76

2.05 ± 0.78

0.412

HDL (mmol/L)

1.05 ± 0.23

1.05 ± 0.26

0.706

1.06 ± 0.26

1.14 ± 0.26

0.246

LDL (mmol/L)

2.81 ± 0.96

2.45 ± 0.84

0.118

2.08 ± 0.76

2.05 ± 0.78

0.412

Lpa (mmol/L)

0.21 ± 0.21

0.20 ± 0.18

0.941

0.21 ± 0.17

0.30 ± 0.49

0.317

ApoA (mmol/L)

1.13 ± 0.22

1.12 ± 0.20

0.764

1.11 ± 0.22

1.12 ± 0.29

0.738

ApoB (mmol/L)

0.93 ± 0.28

0.87 ± 0.26

0.342

0.80 ± 0.25

0.77 ± 0.23

0.225

Ejection Fraction

62.50 ± 9.06

64.01 ± 6.86

0.331

62.62 ± 8.38

62.62 ± 8.20

0.153